ImmunoPrecise Antibodies Ltd. will hold its Annual General Meeting on November 14, 2024, to discuss financials, elect directors, and appoint auditors, based on the notice issued on October 14, 2024. Shareholders must ensure they submit proxies by November 12, 2024, to participate.